drugset / Trial / NCT00366444

Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery

NCT00366444 ↗

Phase 3 Completed 201 enrolled Xanodyne Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.

Timeline

Start
2006-08
Primary completion
2006-10
Completion
—

Outcome

Met primary endpoint

paper DPSGC was associated with significant improvements compared with placebo in mean NPRS score over 48 hours (2.5 vs 5.6, respectively; P < 0.001) PMID 19922878 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 25 mg —

Indications